Literature DB >> 16826318

Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy.

Stéphane Vignes1, Raphaël Porcher, Maria Arrault, Alain Dupuy.   

Abstract

BACKGROUND: Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment.
METHOD: Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy.
RESULTS: Mean volume of lymphedema was 1,054 +/- 633 ml prior and 647 +/- 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91).
CONCLUSION: During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.

Entities:  

Mesh:

Year:  2006        PMID: 16826318     DOI: 10.1007/s10549-006-9297-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

1.  Parameter sensitivity analysis of a lumped-parameter model of a chain of lymphangions in series.

Authors:  Samira Jamalian; Christopher D Bertram; William J Richardson; James E Moore
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-11       Impact factor: 4.733

2.  Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema.

Authors:  Justin C Brown; Andrea L Cheville; Julia C Tchou; Susan R Harris; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2013-09-07       Impact factor: 3.603

3.  A Scoring System to Predict Arm Lymphedema Risk for Individual Chinese Breast Cancer Patients.

Authors:  Ling Wang; Hui-Ping Li; An-Nuo Liu; De-Bin Wang; Ya-Juan Yang; Yan-Qin Duan; Qing-Na Zhang
Journal:  Breast Care (Basel)       Date:  2016-02-03       Impact factor: 2.860

Review 4.  Management of secondary lymphedema related to breast cancer.

Authors:  Oren Cheifetz; Louise Haley
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

5.  A lymphedema self-management programme: report on 30 cases.

Authors:  Dorit Tidhar; Pamela Hodgson; Carol Shay; Anna Towers
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

6.  Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.

Authors:  Marek Ancukiewicz; Cynthia L Miller; Melissa N Skolny; Jean O'Toole; Laura E Warren; Lauren S Jammallo; Michelle C Specht; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2012-06-19       Impact factor: 4.872

7.  Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy.

Authors:  Stéphane Vignes; Raphaël Porcher; Maria Arrault; Alain Dupuy
Journal:  Support Care Cancer       Date:  2010-05-22       Impact factor: 3.603

8.  Self-Management Strategies for Malignant Lymphedema: A Case Report with 1-Year and 4-Year Follow-Up Data.

Authors:  Shirin M Shallwani; Anna Towers
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

9.  Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study.

Authors:  Dorit Tidhar; Michal Katz-Leurer
Journal:  Support Care Cancer       Date:  2009-06-03       Impact factor: 3.603

10.  Diagnosis and treatment of lymphedema after breast cancer: a population-based study.

Authors:  Oksana Sayko; Liliana E Pezzin; Tina W F Yen; Ann B Nattinger
Journal:  PM R       Date:  2013-05-17       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.